A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer

BACKGROUND: Currently, the development of breast cancer immunotherapy based on the PD-1/PD-L1 pathway is relatively slow, and the specific mechanism affecting the immunotherapy efficacy in breast cancer is still unclear. METHODS: Weighted correlation network analysis (WGCNA) and the negative matrix...

Descripción completa

Detalles Bibliográficos
Autores principales: Man, Yuxin, Dai, Chao, Guo, Qian, Jiang, Lingxi, Shi, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167089/
https://www.ncbi.nlm.nih.gov/pubmed/37154982
http://dx.doi.org/10.1007/s12672-023-00669-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167089/
https://www.ncbi.nlm.nih.gov/pubmed/37154982
http://dx.doi.org/10.1007/s12672-023-00669-4

Ejemplares similares